Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

(2012) Antonio Luchicchi et al.   MOLECULAR NEUROBIOLOGY

Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity

(2012) Ana B. Fagundo et al.   PLoS One

Endocannabinoid system dysfunction in mood and related disorders

(2011) C. H. Ashton et al.   ACTA PSYCHIATRICA SCANDINAVICA

Disruptive effects of the prototypical cannabinoid Δ9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats

(2011) Ljiljana Sokolic et al.   BEHAVIOURAL PHARMACOLOGY

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

(2011) Arnau Busquets-Garcia et al.   BIOLOGICAL PSYCHIATRY

An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions

(2011) Rebecca D. Crean et al.   Journal of Addiction Medicine

AAV-Mediated Overexpression of the CB1 Receptor in the mPFC of Adult Rats Alters Cognitive Flexibility, Social Behavior, and Emotional Reactivity

(2011) Matthias Klugmann et al.   Frontiers in Behavioral Neuroscience

Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition

(2011) Tiziana Rubino et al.   Frontiers in Behavioral Neuroscience

Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure

(2010) James J Burston et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight

(2010) Vincenzo Di Marzo   NATURE NEUROSCIENCE

Endocannabinoid chemical biology: a tool for the development of novel therapies

(2009) Stefania Petrosino et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Association ofCNR1andFAAHendocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects

(2009) P. Monteleone et al.   GENES BRAIN AND BEHAVIOR

Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study

(2009) Jeremy Koppel et al.   Lipids in Health and Disease

Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system

(2009) Pauline Lafenêtre et al.   NEUROPHARMACOLOGY

Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition

(2008) Stefan J. Borgwardt et al.   BIOLOGICAL PSYCHIATRY

Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels

(2008) Daniel K. Nomura et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The Endocannabinoid System in Huntingtons Disease

(2008) M. Pazos et al.   CURRENT PHARMACEUTICAL DESIGN

Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa

(2008) René Klinkby Støving et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

(2008) Mauro Maccarrone et al.   NATURE NEUROSCIENCE

Chronic Δ9-Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the Emotional Profile in Adult Rats: Behavioral and Biochemical Correlates

(2008) Tiziana Rubino et al.   NEUROPSYCHOPHARMACOLOGY

FAAH and anandamide: is 2-AG really the odd one out?

(2008) Vincenzo Di Marzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES